OraSure Technologies, Inc. (OSUR) vs SAB Biotherapeutics, Inc. (SABS)
A side-by-side comparison of OraSure Technologies, Inc. and SAB Biotherapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
OSUR
OraSure Technologies, Inc.
$3.77HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
SABS
SAB Biotherapeutics, Inc.
$2.93HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — OSUR vs SABS
growth of $100 · dividends reinvested · last 6yOSUR -73.3% (-19.8%/yr)SABS -96.9% (-44.1%/yr)OSUR compounded faster over this window
Log scale — wide-divergence pair
OSUR SABS
OSUR vs SABS: by the numbers
- •SABS is the larger company ($267M vs $260M market cap).
- •Both run net losses; SABS's is the smaller (0.00% vs -43.70% net margin).
Metrics side by side
Valuation
| Metric | OSUR | SABS |
|---|---|---|
| P/S ratio | 2.31 | N/A |
| P/B ratio | 0.82 | 1.24 |
Profitability
| Metric | OSUR | SABS |
|---|---|---|
| Gross margin | 41.38% | 0.00% |
| Operating margin | -59.23% | 0.00% |
| Net margin | -43.70% | 0.00% |
| ROE | -15.46% | -5.95% |
| ROIC | -15.00% | -31.62% |
Growth (annualized)
| Metric | OSUR | SABS |
|---|---|---|
| Revenue CAGR (5Y) | -13.12% | N/A |
| EPS CAGR (5Y) | N/A | -50.57% |
| Total return CAGR (5Y) | -17.56% | -50.16% |
Frequently asked
- How have OSUR and SABS total returns compared?
- Over the past 5 years, OSUR delivered -17.56% and SABS delivered -50.16% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.